6 Recruiting Hypertension Phase 3 Clinical Trials
Active phase 3 studies for hypertension enrolling across the USA. Verify eligibility and contact site coordinators.
All Hypertension studiesPhase 3 Studies for Hypertension
🔵 Active, Not Recruiting Phase3
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
📍 Accel Research Sites (ARS) - Birmingham Clinical Research Unit — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
TARGET BP I Clinical Trial
📍 Cardiology PC — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
📍 Elite Clinical Studies, LLC — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
📍 Elite Clinical Studies, LLC — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
📍 Elite Clinical Studies, LLC — Phoenix, Arizona
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase3
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
📍 Tennova Turkey Creek Medical Center — Knoxville, Tennessee
View Study & Checklist ➔